PTC Therapeutics | PTCT - Trade Creditors


PTC Therapeutics reported $25.48M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 12.25M 1.34M Mar/2026
Alnylam Pharmaceuticals USD 126.63M 10.91M Mar/2026
Amgen USD 19.52B 1.37B Mar/2026
BioCryst Pharmaceuticals USD 10.96M 4.87M Mar/2026
Biogen USD 358.5M 73.5M Mar/2026
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
Cytokinetics USD 24.71M 80.91M Mar/2026
Daiichi Sankyo JPY 568.5B 16.84B Dec/2025
Enanta Pharmaceuticals USD 1.88M 63K Dec/2025
Esperion Therapeutics USD 68.41M 3.34M Mar/2026
Gilead Sciences USD 645M 70M Mar/2026
Incyte USD 228.62M 1.41B Mar/2026
Ionis Pharmaceuticals USD 26.03M 2.05M Mar/2026
Ironwood Pharmaceuticals USD 3.24M 339K Mar/2026
Karyopharm Therapeutics USD 4M 1.39M Dec/2025
Novartis USD 4.32B 134M Mar/2026
Pfizer USD 4.51B 734M Mar/2026
PTC Therapeutics USD 25.48M 20M Mar/2026
Puma Biotechnology USD 6.39M 962K Sep/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Sarepta Therapeutics USD 70.38M 210.46M Mar/2026
TG Therapeutics USD 148.84M 41.34M Mar/2026
Ultragenyx Pharmaceutical USD 42M 11M Mar/2026
Vertex Pharmaceuticals USD 3.47B 40.6M Mar/2026
Xencor USD 7.92M 2.91M Mar/2026